Keyword: Novo Nordisk

Markets & Companies

After the Big Covid-19 Storm

19.04.2022 -

What does 2022 hold for the biopharma industry? Which companies can play at the forefront in terms of products as well as business? Covid-19 will continue to be a...


Novozymes and Novo Nordisk Partner on Enzymes

30.11.2021 -

Danish companies Novozymes and Novo Nordisk Pharmatech are teaming up to develop technical enzymes to support biopharma processing. The companies aim to develop high...


Novo Nordisk Buys Dicerna Pharmaceuticals

22.11.2021 -

Danish pharma Novo Nordisk has agreed to buy Dicerna Pharmaceuticals, offering $3.3 billion for the US biopharma and its ribonucleic acid interference (RNAi) platform.


Novo Nordisk Takes Prothena’s ATTR Amyloidosis Program

20.07.2021 -

Danish drugmaker Novo Nordisk has acquired Prothena’s clinical-stage stage antibody PRX004 and broader ATTR amyloidosis program, gaining full global rights to the...


Novo Nordisk to Buy Emisphere Technologies

09.11.2020 -

Danish drugmaker Novo Nordisk has agreed to buy US drug delivery company Emisphere Technologies for $1.8 billion.


Evotec Enters Multiple Drug Discovery Pacts

26.08.2020 -

German drug discovery and development company Evotec has struck four separate partnership agreements during August.


Novo Nordisk Buys Cardio-renal Group Corvidia

15.06.2020 - Danish drugmaker Novo Nordisk has agreed to buy Corvidia Therapeutics, a privately held, US-based clinical-stage company focused on the research and development of transformative...


Novo Nordisk to Upgrade Danish Insulin Plant

12.02.2020 - Novo Nordisk has announced it will spend 800 million Danish Kroner (DKK, about $117.4 million) to further upgrade its insulin production site at Kalundborg, Denmark. The site’s...